Source: International Congress 2014 – Bronchoscopy in peripheral pulmonary lesions and diffuse lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Happle, N. Lachmann, J. Skuljec, M. Wetzke, M. Ackermann, S. Brennig, A. Mucci, S. Groos, A. Mirenska, C. Hennig, T. Rodt, J. Bankstahl, N. Schwerk, T. Moritz, G. Hansen (Hannover, Germany). Intrapulmonary transplantation of macrophage progenitors as long-lasting therapy for hereditary pulmonary alveolar proteinosis. Eur Respir J 2014; 44: Suppl. 58, 677

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 Outpatient lobar lavage: a novel approach to managing pulmonary alveolar proteinosis Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches Year: 2020 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Pulmonary alveolar proteinosis in a cat Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Pulmonary alveolar proteinosis due to monocytopenia: Lung transplant or haematopoeitic stem cell transplant? Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency Source: Eur Respir J 2016; 48: 1510-1514 Year: 2016 Successful treatment of alveolar proteinosis by inhaled GM-CSF and intravenous rituximab Source: International Congress 2014 – ILDs 5 Year: 2014 Bronchoscopic intrabullous autologous blood instillation (BIABI) for the treatment of severe bullous emphysema Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we? Year: 2014 Effect of endoscopic lung volume reduction on established pulmonary hypertension in severe emphysema patients Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other Year: 2014 Pulmonary alveolar proteinosis therapy success with combined lavage procedures: a case report Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Pneumothorax in treatment of severe emphysema with endobronchial valves Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other Year: 2014 Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003 Pulmonary perfusion after endoscopic reduction of emphysema Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other Year: 2014 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Treatment of a novel disease with whole lung lavages and stem cell transplantation Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Rituximab therapy in autoimmune pulmonary alveolar proteinosis Source: Eur Respir J 2009; 33: 1503-1506 Year: 2009 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Inhaled GM-CSF in pulmonary alveolar proteinosis (PAP) patient refractory to plasmapheresis combined with multiple whole lung lavages (WLL) Source: International Congress 2016 – Orphan diseases I Year: 2016